Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2007 Filed Mar 9, 2007 19:52 UTC |
Caldarella Joseph CVP & Financial Controller
|
Tax withholdingCommon Stock, $0.10 par value | 435 | $27.12 | $11,797.20 |
DisclosureSEC source: 0000014272-07-000085 · cal686.xml · nonDerivative · entry 1 Caldarella Joseph C · CIK 0001341069 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,093 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 07, 2007 Filed Mar 9, 2007 19:52 UTC |
LEUNG SANDRASVP and General Counsel
|
Tax withholdingCommon Stock, $0.10 par value | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000086 · leu687.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,046 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
GrantRestricted Stock Units · Derivative | 19,800 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock, $0.10 par value · 19,800 shares Expires 2017-03-05 F5 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
GrantExecutive Option (right to buy) · Derivative | 234,720 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,720 Underlying: Common Stock, $0.10 par value · 234,720 shares Expires 2017-03-05 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
Tax withholdingCommon Stock, $0.10 par value | 2,515 | $27.01 | $67,930.15 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,497 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:17 UTC |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
GrantCommon Stock, $0.10 par value | 5,261 | $27.01 | $142,099.61 |
DisclosureSEC source: 0000014272-07-000076 · and678.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,012 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BEAR STEPHEN ESVP, Human Resources
|
GrantRestricted Stock Units · Derivative | 7,125 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000077 · bea679.xml · derivative · entry 5 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock, $0.10 par value · 7,125 shares Expires 2017-03-05 F6 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BEAR STEPHEN ESVP, Human Resources
|
GrantExecutive Option (right to buy) · Derivative | 81,500 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000077 · bea679.xml · derivative · entry 4 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,500 Underlying: Common Stock, $0.10 par value · 81,500 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BEAR STEPHEN ESVP, Human Resources
|
Tax withholdingCommon Stock, $0.10 par value | 1,002 | $27.01 | $27,064.02 |
DisclosureSEC source: 0000014272-07-000077 · bea679.xml · nonDerivative · entry 2 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,325 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BEAR STEPHEN ESVP, Human Resources
|
GrantCommon Stock, $0.10 par value | 2,964 | $27.01 | $80,057.64 |
DisclosureSEC source: 0000014272-07-000077 · bea679.xml · nonDerivative · entry 1 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,327 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BONFIELD ANDREW R JEVP & CFO
|
GrantRestricted Stock Units · Derivative | 19,800 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000078 · bon680.xml · derivative · entry 5 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock, $0.10 par value · 19,800 shares Expires 2017-03-05 F6 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BONFIELD ANDREW R JEVP & CFO
|
GrantExecutive Option (right to buy) · Derivative | 234,720 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000078 · bon680.xml · derivative · entry 4 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,720 Underlying: Common Stock, $0.10 par value · 234,720 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BONFIELD ANDREW R JEVP & CFO
|
Tax withholdingCommon Stock, $0.10 par value | 2,412 | $27.01 | $65,148.12 |
DisclosureSEC source: 0000014272-07-000078 · bon680.xml · nonDerivative · entry 2 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,164 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
BONFIELD ANDREW R JEVP & CFO
|
GrantCommon Stock, $0.10 par value | 5,261 | $27.01 | $142,099.61 |
DisclosureSEC source: 0000014272-07-000078 · bon680.xml · nonDerivative · entry 1 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,576 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
Caldarella Joseph CVP & Financial Controller
|
GrantRestricted Stock Units · Derivative | 5,647 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000079 · cal681.xml · derivative · entry 2 Caldarella Joseph C · CIK 0001341069 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,647 Underlying: Common Stock, $0.10 par value · 5,647 shares Expires 2017-03-05 F2 · derivative.exercise_date: Shares consist of restricted stock that vests 25% on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
Caldarella Joseph CVP & Financial Controller
|
GrantOption (right to buy) · Derivative | 22,598 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000079 · cal681.xml · derivative · entry 1 Caldarella Joseph C · CIK 0001341069 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,598 Underlying: Common Stock, $0.10 par value · 22,598 shares Expires 2017-03-05 F1 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
Celentano John EPresident, Health Care Group
|
GrantRestricted Stock Units · Derivative | 12,770 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,770 Underlying: Common Stock, $0.10 par value · 12,770 shares Expires 2017-03-05 F6 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
Celentano John EPresident, Health Care Group
|
GrantExecutive Option (right to buy) · Derivative | 51,090 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,090 Underlying: Common Stock, $0.10 par value · 51,090 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
Celentano John EPresident, Health Care Group
|
Tax withholdingCommon Stock, $0.10 par value | 433 | $27.01 | $11,695.33 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,565 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
Celentano John EPresident, Health Care Group
|
GrantCommon Stock, $0.10 par value | 1,465 | $27.01 | $39,569.65 |
DisclosureSEC source: 0000014272-07-000080 · cel682.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,998 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
LEUNG SANDRASVP and General Counsel
|
GrantRestricted Stock Units · Derivative | 10,200 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000081 · leu683.xml · derivative · entry 2 LEUNG SANDRA · CIK 0001199294 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock, $0.10 par value · 10,200 shares Expires 2017-03-05 F2 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
LEUNG SANDRASVP and General Counsel
|
GrantExecutive Option (right to buy) · Derivative | 116,100 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000081 · leu683.xml · derivative · entry 1 LEUNG SANDRA · CIK 0001199294 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,100 Underlying: Common Stock, $0.10 par value · 116,100 shares Expires 2017-03-05 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
SIGAL ELLIOTEVP, CSO & President PRI
|
GrantRestricted Stock Units · Derivative | 20,625 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000082 · sig684.xml · derivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Common Stock, $0.10 par value · 20,625 shares Expires 2017-03-05 F6 · derivative.exercise_date: Consists of restricted stock units with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
SIGAL ELLIOTEVP, CSO & President PRI
|
GrantExecutive Option (right to buy) · Derivative | 244,500 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000082 · sig684.xml · derivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,500 Underlying: Common Stock, $0.10 par value · 244,500 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
SIGAL ELLIOTEVP, CSO & President PRI
|
Tax withholdingCommon Stock, $0.10 par value | 1,052 | $27.01 | $28,414.52 |
DisclosureSEC source: 0000014272-07-000082 · sig684.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,153 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed Mar 8, 2007 22:18 UTC |
SIGAL ELLIOTEVP, CSO & President PRI
|
GrantCommon Stock, $0.10 par value | 2,264 | $27.01 | $61,150.64 |
DisclosureSEC source: 0000014272-07-000082 · sig684.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,205 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
GrantRestricted Stock Units · Derivative | 19,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · derivative · entry 4 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock, $0.10 par value · 19,800 shares Expires not disclosed F5 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F6 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F6 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
GrantExecutive Option (right to buy) · Derivative | 234,720 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · derivative · entry 3 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,720 Underlying: Common Stock, $0.10 par value · 234,720 shares Expires 2017-03-05 F4 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
Tax withholdingCommon Stock, $0.10 par value | 2,515 | $27.01 | $67,930.15 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · nonDerivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,497 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
ANDREOTTI LAMBERTOEVP BMS & President WW Pharm
|
GrantCommon Stock, $0.10 par value | 5,261 | $27.01 | $142,099.61 |
DisclosureSEC source: 0000014272-07-000122 · and702.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · EVP BMS & President WW Pharm 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,012 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BEAR STEPHEN ESVP, Human Resources
|
GrantRestricted Stock Units · Derivative | 7,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000124 · bea699.xml · derivative · entry 5 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock, $0.10 par value · 7,125 shares Expires not disclosed F6 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F7 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BEAR STEPHEN ESVP, Human Resources
|
GrantExecutive Option (right to buy) · Derivative | 81,500 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000124 · bea699.xml · derivative · entry 4 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,500 Underlying: Common Stock, $0.10 par value · 81,500 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BEAR STEPHEN ESVP, Human Resources
|
Tax withholdingCommon Stock, $0.10 par value | 1,002 | $27.01 | $27,064.02 |
DisclosureSEC source: 0000014272-07-000124 · bea699.xml · nonDerivative · entry 2 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,325 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BEAR STEPHEN ESVP, Human Resources
|
GrantCommon Stock, $0.10 par value | 2,964 | $27.01 | $80,057.64 |
DisclosureSEC source: 0000014272-07-000124 · bea699.xml · nonDerivative · entry 1 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,327 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BONFIELD ANDREW R JEVP & CFO
|
GrantRestricted Stock Units · Derivative | 19,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000125 · bon704.xml · derivative · entry 5 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Underlying: Common Stock, $0.10 par value · 19,800 shares Expires not disclosed F6 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F7 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BONFIELD ANDREW R JEVP & CFO
|
GrantExecutive Option (right to buy) · Derivative | 234,720 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000125 · bon704.xml · derivative · entry 4 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,720 Underlying: Common Stock, $0.10 par value · 234,720 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BONFIELD ANDREW R JEVP & CFO
|
Tax withholdingCommon Stock, $0.10 par value | 2,412 | $27.01 | $65,148.12 |
DisclosureSEC source: 0000014272-07-000125 · bon704.xml · nonDerivative · entry 2 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,164 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
BONFIELD ANDREW R JEVP & CFO
|
GrantCommon Stock, $0.10 par value | 5,261 | $27.01 | $142,099.61 |
DisclosureSEC source: 0000014272-07-000125 · bon704.xml · nonDerivative · entry 1 BONFIELD ANDREW R J · CIK 0001199292 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,576 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
Caldarella Joseph CVP & Financial Controller
|
GrantRestricted Stock Units · Derivative | 5,647 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000126 · cal701.xml · derivative · entry 2 Caldarella Joseph C · CIK 0001341069 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,647 Underlying: Common Stock, $0.10 par value · 5,647 shares Expires not disclosed F2 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: Twenty-five percent of the restricted stock units will vest on each of the first, second, third and fourth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: Twenty-five percent of the restricted stock units will vest on each of the first, second, third and fourth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
Caldarella Joseph CVP & Financial Controller
|
GrantOption (right to buy) · Derivative | 22,598 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000126 · cal701.xml · derivative · entry 1 Caldarella Joseph C · CIK 0001341069 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,598 Underlying: Common Stock, $0.10 par value · 22,598 shares Expires 2017-03-05 F1 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
Celentano John EPresident, Health Care Group
|
GrantRestricted Stock Units · Derivative | 12,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · derivative · entry 5 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,770 Underlying: Common Stock, $0.10 par value · 12,770 shares Expires not disclosed F6 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F7 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
Celentano John EPresident, Health Care Group
|
GrantExecutive Option (right to buy) · Derivative | 51,090 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · derivative · entry 4 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,090 Underlying: Common Stock, $0.10 par value · 51,090 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
Celentano John EPresident, Health Care Group
|
Tax withholdingCommon Stock, $0.10 par value | 433 | $27.01 | $11,695.33 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · nonDerivative · entry 2 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,565 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
Celentano John EPresident, Health Care Group
|
GrantCommon Stock, $0.10 par value | 1,465 | $27.01 | $39,569.65 |
DisclosureSEC source: 0000014272-07-000127 · cel700.xml · nonDerivative · entry 1 Celentano John E · CIK 0001346102 · President, Health Care Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,998 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
LEUNG SANDRASVP and General Counsel
|
GrantRestricted Stock Units · Derivative | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000128 · leu705.xml · derivative · entry 2 LEUNG SANDRA · CIK 0001199294 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 Underlying: Common Stock, $0.10 par value · 10,200 shares Expires not disclosed F2 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:19 UTC Amendment |
LEUNG SANDRASVP and General Counsel
|
GrantExecutive Option (right to buy) · Derivative | 116,100 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000128 · leu705.xml · derivative · entry 1 LEUNG SANDRA · CIK 0001199294 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,100 Underlying: Common Stock, $0.10 par value · 116,100 shares Expires 2017-03-05 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:20 UTC Amendment |
SIGAL ELLIOTEVP, CSO & President PRI
|
GrantRestricted Stock Units · Derivative | 20,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000129 · sig703.xml · derivative · entry 5 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Common Stock, $0.10 par value · 20,625 shares Expires not disclosed F6 · derivative.exercise_price: This Form 4 is being amended to clarify that each restricted stock unit converts into one share of common stock upon vesting. F7 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F7 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:20 UTC Amendment |
SIGAL ELLIOTEVP, CSO & President PRI
|
GrantExecutive Option (right to buy) · Derivative | 244,500 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0000014272-07-000129 · sig703.xml · derivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,500 Underlying: Common Stock, $0.10 par value · 244,500 shares Expires 2017-03-05 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:20 UTC Amendment |
SIGAL ELLIOTEVP, CSO & President PRI
|
Tax withholdingCommon Stock, $0.10 par value | 1,052 | $27.01 | $28,414.52 |
DisclosureSEC source: 0000014272-07-000129 · sig703.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,153 F3 · shares: Shares withheld for payment of taxes. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2007 Filed May 10, 2007 21:20 UTC Amendment |
SIGAL ELLIOTEVP, CSO & President PRI
|
GrantCommon Stock, $0.10 par value | 2,264 | $27.01 | $61,150.64 |
DisclosureSEC source: 0000014272-07-000129 · sig703.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · EVP, CSO & President PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,205 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.